Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic bioavailability and tolerability of a new Somatoline gel formulation in healthy women
2018-002380-26Phase 2Completed
- Sponsor
- Manetti & Roberts
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Somatoline in cellulite and dermatoses, sponsored by Manetti & Roberts. Primary endpoint: Systemic bioavailability of l-T4. Started Nov 2020; status: completed.
02
Drugs
Somatoline
03
Conditions
cellulitedermatoses
Beyond the preview
Go deeper on 2018-002380-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002380-26.